Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Argus Health
Deloitte
Harvard Business School
Mallinckrodt
Chubb
Novartis
Fuji
Colorcon
Cipla

Generated: October 18, 2017

DrugPatentWatch Database Preview

VALCHLOR Drug Profile

« Back to Dashboard

What is the patent landscape for Valchlor, and what generic Valchlor alternatives are available?

Valchlor is a drug marketed by Actelion Pharms Ltd and is included in one NDA. There are six patents protecting this drug.

This drug has twenty-eight patent family members in seventeen countries and three supplementary protection certificates in three countries.

The generic ingredient in VALCHLOR is mechlorethamine hydrochloride. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the mechlorethamine hydrochloride profile page.

Summary for Tradename: VALCHLOR

US Patents:6
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list24
Clinical Trials: see list4
Patent Applications: see list3,330
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VALCHLOR at DailyMed

Pharmacology for Tradename: VALCHLOR

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity

Non-Orange Book Patents for Tradename: VALCHLOR

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,010,029,783► Subscribe
8,664,278Stabilized compositions of volatile alkylating agents and methods of using thereof► Subscribe
8,501,817Stabilized compositions of alkylating agents and methods of using same► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: VALCHLOR

Country Document Number Estimated Expiration
European Patent Office1858864► Subscribe
Cyprus1113305► Subscribe
World Intellectual Property Organization (WIPO)2009120493► Subscribe
HungaryS1700033► Subscribe
Spain2388744► Subscribe
Japan2008533152► Subscribe
Japan5671514► Subscribe
Poland1858864► Subscribe
Japan5236457► Subscribe
South Korea20070120163► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: VALCHLOR

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017 00033Denmark► SubscribePRODUCT NAME: CHLORMETHINE, HERUNDER CHLORMETHINE HYDROCHLORIDE; REG. NO/DATE: EU/1/16/1171 20170307
0888Netherlands► SubscribePRODUCT NAME: CHLORMETHINE, ALSMEDE DE THERAPEUTISCH EQUIVALENTE VARIANTEN ER VAN ZOALS BESCHERMD DOOR HET BASISOCTROOI; REGISTRATION NO/DATE: EU/1/16/1171 20170307
2017026Lithuania► SubscribePRODUCT NAME: CHLORMETINAS; REGISTRATION NO/DATE: EU/1/16/1171 20170303
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Citi
Merck
Cerilliant
UBS
Harvard Business School
Fuji
QuintilesIMS
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot